A citation-based method for searching scientific literature

A Tibben, M Stevens, G M de Wert, M F Niermeijer, C M van Duijn, J C van Swieten. J Med Genet 1997
Times Cited: 27







List of co-cited articles
210 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia.
E J Steinbart, C O Smith, P Poorkaj, T D Bird. Arch Neurol 2001
78
37

Public attitudes about genetic testing for Alzheimer's disease.
P J Neumann, J K Hammitt, C Mueller, H M Fillit, J Hill, N A Tetteh, K S Kosik. Health Aff (Millwood) 2001
70
25

The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
348
25

Genetic counseling in a Swedish Alzheimer family with amyloid precursor protein mutation.
L Lannfelt, K Axelman, L Lilius, H Basun. Am J Hum Genet 1995
29
22




Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.
J Scott Roberts, Susan A LaRusse, Heather Katzen, Peter J Whitehouse, Melissa Barber, Stephen G Post, Norman Relkin, Kimberly Quaid, Robert H Pietrzak, L Adrienne Cupples,[...]. Alzheimer Dis Assoc Disord 2003
66
22

Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
184
22

Disclosure of APOE genotype for risk of Alzheimer's disease.
Robert C Green, J Scott Roberts, L Adrienne Cupples, Norman R Relkin, Peter J Whitehouse, Tamsen Brown, Susan LaRusse Eckert, Melissa Butson, A Dessa Sadovnick, Kimberly A Quaid,[...]. N Engl J Med 2009
326
22

Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
104
18

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
18

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
604
18

Attitudes toward predictive testing for Alzheimer's disease in a student population.
M Welkenhuysen, G Evers-Kiebooms, H Van den Berghe. Psychiatr Genet 1997
13
38


Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
84
18

Uptake of presymptomatic predictive testing for Huntington's disease.
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
181
18

Molecular genetic predictive testing for Alzheimer's disease: deliberations and preliminary recommendations.
A Lennox, H Karlinsky, W Meschino, J A Buchanan, M E Percy, J M Berg. Alzheimer Dis Assoc Disord 1994
27
18


Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior.
Cathleen D Zick, Charles J Mathews, J Scott Roberts, Robert Cook-Deegan, Robert J Pokorski, Robert C Green. Health Aff (Millwood) 2005
78
18



Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.
B B Biesecker, M Boehnke, K Calzone, D S Markel, J E Garber, F S Collins, B L Weber. JAMA 1993
250
14

Predictors of psychological adjustment to genetic testing for Huntington's disease.
A M Codori, P R Slavney, C Young, D L Miglioretti, J Brandt. Health Psychol 1997
64
14



On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
95
14


Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.
D Campion, C Dumanchin, D Hannequin, B Dubois, S Belliard, M Puel, C Thomas-Anterion, A Michon, C Martin, F Charbonnier,[...]. Am J Hum Genet 1999
499
14

Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.
I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
104
14

The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.
S G Post, P J Whitehouse, R H Binstock, T D Bird, S K Eckert, L A Farrer, L M Fleck, A D Gaines, E T Juengst, H Karlinsky,[...]. JAMA 1997
145
14

Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial.
J Scott Roberts, Melissa Barber, Tamsen M Brown, L Adrienne Cupples, Lindsay A Farrer, Susan A LaRusse, Stephen G Post, Kimberly A Quaid, Lisa D Ravdin, Norman R Relkin,[...]. Genet Med 2004
78
14

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
14

Understanding the decision to take the predictive test for Huntington disease.
G J Meissen, C A Mastromauro, D K Kiely, D S McNamara, R H Myers. Am J Med Genet 1991
52
14

Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.
J Scott Roberts, L Adrienne Cupples, Norman R Relkin, Peter J Whitehouse, Robert C Green. J Geriatr Psychiatry Neurol 2005
95
14

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
L A Farrer, L A Cupples, J L Haines, B Hyman, W A Kukull, R Mayeux, R H Myers, M A Pericak-Vance, N Risch, C M van Duijn. JAMA 1997
14

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.
Serena Chao, J Scott Roberts, Theresa M Marteau, Rebecca Silliman, L Adrienne Cupples, Robert C Green. Alzheimer Dis Assoc Disord 2008
166
14

Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk.
Holly C Gooding, Erin L Linnenbringer, Jeffrey Burack, J Scott Roberts, Robert C Green, Barbara B Biesecker. Patient Educ Couns 2006
44
14

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene.
E I Rogaev, R Sherrington, E A Rogaeva, G Levesque, M Ikeda, Y Liang, H Chi, C Lin, K Holman, T Tsuda. Nature 1995
14

Candidate gene for the chromosome 1 familial Alzheimer's disease locus.
E Levy-Lahad, W Wasco, P Poorkaj, D M Romano, J Oshima, W H Pettingell, C E Yu, P D Jondro, S D Schmidt, K Wang. Science 1995
14

Emotional reactions to predictive testing in Alzheimer's disease and other inherited dementias.
José L Molinuevo, Luis Pintor, Josep M Peri, Alberto Lleó, Rafael Oliva, Teodor Marcos, Rafael Blesa. Am J Alzheimers Dis Other Demen 2005
27
14

Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors.
Jill S Goldman, Susan E Hahn, Jennifer Williamson Catania, Susan LaRusse-Eckert, Melissa Barber Butson, Malia Rumbaugh, Michelle N Strecker, J Scott Roberts, Wylie Burke, Richard Mayeux,[...]. Genet Med 2011
183
14

Self-selection in predictive testing for Huntington's disease.
A M Codori, R Hanson, J Brandt. Am J Med Genet 1994
115
14



Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
263
11

BRCA1 in the family: a case description of the psychological implications.
A C DudokdeWit, A Tibben, P G Frets, E J Meijers-Heijboer, P Devilee, J G Klijn, J C Oosterwijk, M F Niermeijer. Am J Med Genet 1997
67
11

Attitudes of persons at risk for Huntington disease toward predictive testing.
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
159
11

Early detection of Alzheimer disease: methods, markers, and misgivings.
R C Green, V C Clarke, N J Thompson, J L Woodard, R Letz. Alzheimer Dis Assoc Disord 1997
20
15

Family members' attitudes toward telling the patient with Alzheimer's disease their diagnosis.
C P Maguire, M Kirby, R Coen, D Coakley, B A Lawlor, D O'Neill. BMJ 1996
96
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.